Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity
Second study shows 7.2 mg semaglutide leads to greater reductions in mean body weight for those with obesity, T2D
Evidence Insufficient to Determine Benefits of Multicancer Screening Tests
Sensitivity ranged from 0.095 to 0.998; specificity from 0.657 to 1.0; AUC from 0.52 to 1.0 across tests
High Exposure to Prenatal Prescribed Opioid Analgesics Likely Not Associated With ASD Risk
Associations were largely or fully attenuated using designs other than accounting for measured confounders and in sibling comparisons
Orange B Food Dye May Soon Be Removed From U.S. Market, FDA Says
The food dye has not been used since 1978; advocates say the move has little impact on today’s food supply
OpenAI Launches Teen-Safe ChatGPT With Parental Controls
The move comes as regulators increase scrutiny of chatbots and their impact on young people’s mental health
Boar’s Head Faces Pressure From Congress Over Plans to Reopen After Listeria Deaths
Sanitation problems at other Boar's Head facilities are raising more safety concerns
Smoking Tied to Increased Risk for Type 2 Diabetes
People with a genetic susceptibility to developing diabetes may be more vulnerable to the adverse effects of smoking
Long COVID Linked to Abnormal Uterine Bleeding
Higher serum 5α-dihydrotestosterone and lower endometrial androgen receptors seen in long COVID
GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity
Tirzepatide offers more favorable return on investment, but greater benefits seen at lower costs for Roux-en-Y gastric bypass
Without Biannual Time Shift, Prevalence of Obesity, Stroke May Be Reduced
Modeling study shows decrease in prevalence of both obesity and stroke under Standard Time, Daylight Saving Time versus current policy
